baber/WOPTO huggingface dataset:
Patent NZ-334158-A (NZ)
Title: Measuring diameter of fibres, using light beam passed through cell containing fibre
Inventor: DABBS TIMOTHY PETER
IPC: G01B11/08
Filed: 1999-02-12
Abstract: Disclosed is a method/apparatus to determine any one of a plurality of parameters: shape, area, chemical composition, diameter, colour, number, thickness, width, length, absorptivity, reflectivity, transmittivity, dielectric constant, raman scattering profile, fluorescence, surface tension, roughness, profile, density, position and orientation. Also use of a plurality of energy beams as source energy: charged and neutral particle beams, gamma-, X-, micro-, optical and acoustic waves. The described apparatus determines the mean and standard deviation of a plurality of diameters of wool fibres, and includes a He-Ne laser (101), and a pinhole (102) which produce an expanding laser beam which passes through cell (105). Beam splitter (103) is operatively disposed to pinhole (102) and laser (101) to direct a portion of the laser beam to reference detector (109) which is electrically connected to processor (110) via line (111). When apparatus (100) is operating wool fibres in an isopropanol-wool slurry pass through cell (105) generally at a non-zero degree angle to the direction of slurry flow through cell (105) to interact with the laser beam in cell (105). Beam splitter (104) and microscope objective (106) are operatively disposed with respect to laser (101), pinhole (102) and cell (105)to produce an in focus magnified transmission image of wool fibres in cell (105) in the plane of end (107) of optical fibre bundle (108). Each of the fibres in bundle (108) is connected to a photodiode detector (112). Processor/timer (113) is connected electrically to detector (112) by line (114). Processor/timer (113) is also connected electrically to computer (115) by line (116) and to processor (110) by line (117). Detector (118) is connected electrically to processor (110) by line (119). Processor (110) is connected electrically to computer (115) by line (120). Detector (118) is operatively disposed with respect to laser (101), pinhole (102) and cell (105) to detect outgoing light.
Patent NZ-335994-A (NZ)
Title: Sevoflurane compositions and methods for inhibiting their degradation in the presence of a lewis acid
Inventor: BIENIARZ CHRISTOPHER
IPC: A61P23/00
Filed: 1998-01-23
Abstract: An anesthetic composition containing sevoflurane and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not degrade in the presence of a Lewis acid.
Patent NZ-336802-A (NZ)
Title: Process for the manufacture of carboxylic acids
Inventor: BREED ANTHONIUS JOHANNES MARIA
IPC: C07C51/12
Filed: 1998-02-24
Abstract: A process for manufacture of branched carboxylic acids from branched olefins by means of reaction with carbon monoxide and a solid acid catalyst, characterized in that a branched olefin, or a precursor thereof, is reacted in continuously backmixed reactor, with continuously supplied carbon monoxide and water, while continuously, an effluent is withdrawn comprising branched carboxylic acid, non-converted olefin, carbon monoxide and water, in the presence of an acidic ion exchanger, having sufficient acid groups to provide requisite protons for conversion of said olefin or a precursor of it, and carbon monoxide, into branched carboxylic acids.
Patent NZ-501835-A (NZ)
Title: Process for the preparation of a substituted perhydroisoindole
Inventor: LECOUVE JEAN-PIERRE
IPC: C07D209/44
Filed: 1998-07-01
Abstract: The industrial preparation of a substituted perhydroisoindole of formula (I) or a pharmaceutically acceptable salt thereof comprises:  a)	reacting dimethyl succinate with benzaldehyde in a methanolic medium to produce the diacid of formula (II); b)	the diacid (II) is heated in an aprotic medium in the presence of acetic anhydride to produce the anhydride of formula (III); c)	the anhydride (III) is reacted with perhydroisoindole of formula (IV) in an aprotic solvent to produce the compound of formula (V); d)	compound (V) is subjected to catalytic hydrogenation using as asymmetric hydrogenation catalyst the complex rhodium/(2S, 4S)-N-butoxycarbonyl-4-diphenylphosphino-2-diphenylphosphino-methylpyrrolidine or Rh/(S,S) BPPM in methanolic or methylene chloride medium followed by conversion to a salt in the presence of an amine A to produce a compound of formula (VI); e)	compound (VI) in a basic medium in the presence of a mineral salt yields an addition salt of the compound of formula (I) which is converted optionally into the corresponding acid or f)	compound (VI) in an acidic medium yields the compound of formula (I) which is converted optionally into a pharmaceutically acceptable addition salt.
Patent NZ-503174-A (NZ)
Title: A synergistic combination of a benzopyran selective 5-HT 1A antagonist and a selective h5-HT 1B antagonist or partial agonist
Inventor: BERG STEFAN
IPC: A61K31/535
Filed: 1998-09-09
Abstract: The synergistic combination of a first component which is a selective 5-HT1A receptor antagonist of formula (I), and a second component which is a selective h5-HT1B antagonist or partial agonist having the formula II, may be used in methods of treating affective disorders such as depression, anxiety and obsessive compulsive disorder. In formula I, R1 is n-propyl or cyclobutyl; R2 is isopropyl, tertiary butyl, cyclobutyl, cyclopentyl or cyclohexyl; R3 is hydrogen; and R4 is hydrogen or methyl.  In formula II, X is CH2 or O, Y is CONH, NHCO, R1 is H, C1-C6 alkyl or C3-C6 cycloalkyl; R2 is H, C1-C6 alkyl, C1-C6 alkoxy or halogen; R3 is selected from the groups depicted above; and  R4 and R5 are H or C1-C4 alkyl.
Patent NZ-506602-A (NZ)
Title: Combined vaccine compositions against hepatitis B virus and herpes simplex virus and possibly also epstein bar virus, hepatitis A & C viruses, human papilloma virus, varicella zoster virus, human cytomegalovirus, and toxoplasma gondii
Inventor: STEPHENNE JEAN
IPC: A61P37/04
Filed: 1999-03-04
Abstract: A vaccine composition comprising: (a) A hepatitis B surface antigen; and (b) A Herpes simplex virus gD antigen. In conjunction with an adjuvant which is a preferential stimulator of TH1 cell response wherein the HBV antigen and the HSV antigen are not covalently linked to each other, and wherein the immune response to each antigen in the composition is essentially the same as that which is obtained by each antigen given individually.
Patent NZ-508444-A (NZ)
Title: Using (R)-N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3- pyridazinyl)phenyl]acetamide for treating heart failure
Inventor: HAIKALA HEIMO
IPC: C07D237/14
Filed: 1999-05-26
Abstract: (R)-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3- pyridazinyl)phenyl]acetamide may be used for  the  treatment of  neurohumoral imbalance caused by alterations of  cardiac function  to  prevent the development of heart  failure  and may  also  be  used to increase the calcium  sensitivity  of contractile  proteins of cardiac muscle  by  increasing  the contractility  of  the  cardiac  muscle  by  increasing  the calcium   current  into  the  cardiac  muscle  and   produce vasodilatation.
Patent NZ-511358-A (NZ)
Title: Timber stacking and sorting apparatus
Inventor: REID JOHN LESLIE
IPC: G01B21/32
Filed: 2001-04-27
Abstract: An apparatus for sorting and stacking a product such as timber boards includes a grading means (13) for grading the product and delivering means (14) for delivering the product to a selected stacking module (20).  The stacking module (32) includes a storage means (30) arranged to store a number of the product until there are sufficient stored products to form a layer of stored products.  The layer of stored products are arranged to be moved onto a stacking means with the stacking means being positioned relative to a receipt means such that when the stacking means is retracted the layer of stored products is stacked onto the receipt means.  The consecutive layers of stored products form layers of products on the receipt means.
Patent NZ-512583-A (NZ)
Title: Pulmonary aerosol delivery device and method
Inventor: ZIMLICH WILLIAM C
IPC: B05B5/00
Filed: 1999-12-22
Abstract: A device and method for delivering an aerosolized liquid having therapeutic properties to a user's lungs. The compact and convenient device includes a housing of such size that it can be held in a user's one hand with an exit opening in the housing for directing the aerosol to the user's mouth. The housing encloses a dispensing system for containing the liquid to be aerosolized and delivering it to an electrohydrodynamic apparatus and an electrohydrodynamic apparatus for aerosolizing the liquid and delivering the aerosol to the exit opening. The electrohydrodynamic apparatus produces a cloud of aerosolized liquid droplets having a monodispersed respirable droplet size and near zero velocity. The aerosolizing apparatus includes a plurality of spray sites each having a tip end, the spray sites cooperating with a charge source to result in an aerosolized spray from at least one tip end, a plurality of discharge electrodes downstream of the tip ends, and a plurality of reference electrodes downstream of the plurality of discharge electrodes
Patent NZ-518006-A (NZ)
Title: Hand-held apparatus for installing flashover protection covers on energized electrical conductors and equipment
Inventor: FRYE TERRY E
IPC: H02G3/04
Filed: 2000-09-29
Abstract: Hand-held devices that can be used to quickly install flashover protection covers around energized electrical conductors and equipment are provided. Each device includes a guide assembly that defines a pair of spaced-apart, converging passageways that are configured to slidably receive the elongated edge portions of a flexible panel there through. The converging passageways force together the opposite edge portions of a flexible panel being advanced through the guide assembly.
Patent NZ-520842-A (NZ)
Title: Pyrrolopyrimidinone derivatives, process of preparation and use
Inventor: CHOI WON-SON
IPC: A61P13/12
Filed: 2001-02-15
Abstract: Pyrrolopyrimidinone compounds of formula (1) are disclosed, for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for use as PDE V inhibitors.
Patent NZ-522456-A (NZ)
Title: Method and means for handling extruded reconstituted tobacco filament
Inventor: LEWIS WILLIAM DAVID
IPC: A24B3/14
Filed: 2001-05-08
Abstract: A method for the extrusion of filamentary strands of reconstituted tobacco through a die plate and the downstream handling thereof is disclosed, wherein the die plate is configured such that each filament is of a square or rectangular cross-section, the downstream handling of which effects draw down of the extruded filament.
Patent NZ-522608-A (NZ)
Title: Material comprising a liquid crystal polymer for packing a nicotine-containing product
Inventor: LEVANDER GUSTAV
IPC: C08L101/00
Filed: 2000-01-12
Abstract: A method for packaging a nicotine-containing product comprises placing the product in a package comprising a packaging material. The packaging material comprises a liquid crystal polymer, LCP.  The LCP preferably comprises hydroxy benzoic acid and hydroxy naphtenic acid and the packaging material may further comprise one ore more further polymers. The product could comprise a patch for transdermally administrating nicotine, a nicotine containing chewing gum, a nicotine containing tablet, a spray for nasal administration of nicotine or a device for inhaling nicotine.
Patent NZ-523450-A (NZ)
Title: Nonpeptide substituted spirobenzoazepines as vasopressin receptor antagonists
Inventor: CHEN ROBERT H
IPC: C07D401/10
Filed: 2001-07-02
Abstract: Nonpeptide substituted benzodiazepines of Formula (I) are disclosed, wherein A, X, n, R1, R2, R3, R4, R5, a and b are as described in the specification, which are useful as vasopressin receptor antagonists for treating conditions associated with vasopressin receptor activity such as those involving increased vascular resistance and cardiac insufficiency. Pharmaceutical compositions comprising a compound of Formula (I) and methods of treating conditions such as hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis, or water retention are also disclosed.
Patent NZ-524278-A (NZ)
Title: Fluid mixer with apertured duct and overlying rotatable sleeve
Inventor: METCALFE GUY PARKER
IPC: B01F29/60
Filed: 2001-09-07
Abstract: A fluid mixer includes an inner fluid flow (11) duct having a cylindrical wall (14) provided with the window openings (13) and an outer tubular sleeve (12) disposed outside and extending along the duct (11) to cover the openings (13). Fluids to be mixed are admitted to one end of duct (11) through an inlet (25) and the mixture flows out through outlet (32). Duct (11) is statically mounted in pedestals (15) fixed to a base platform (17). Sleeve (12) is mounted for rotation in further pedestals (16) and driven by motor (23) and drive belt (22) to rotate concentrically about duct (11) such that parts of the sleeve move across the window openings (13) to create viscous drag on fluid flowing through the duct and transverse flows of fluid in the regions of the openings to promote mixing.
Patent NZ-525795-A (NZ)
Title: Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Inventor: HEWITT WILLIAM
IPC: A61P3/10
Filed: 2001-11-15
Abstract: A pharmaceutical composition comprising the renin inhibitor of formula (I), an angiotensin converting enzyme (ACE) inhibitor, and a carrier; the use of a combination of the renin inhibitor for formula (I) with an angiotensin converting enzyme (ACE) inhibitor for the manufacture of a medicament for the prevention of, delay of progression of or treatment of a disease or condition selected from the group consisting of: (a) hypertension, congestive heart failure renal failure, restenosis after percutaneous transluminal angioplasty and restenosis after coronary artery bypass surgery; (b)atherosclerosis, insulin resistance and syndrome X, diabetes mellitus type 2, obesity, nephropathy, renal failure e.g. chronic renal failure, hypothyroidism, survival post myocardial infarction (MI), coronary heart diseases, hypertension in the elderly, familial dyslipidemic hypertension, increase of formation of collagen, fibrosis and remodeling following hypertension (antiproliferative effect of the combination), all these diseases or conditions associated with or without hypertension; (c) endothelial dysfunction with or without hypertension, comprising administering the pharmaceutical composition; (d) hyperlipidemia, hyperlipoproteinemia, atherosclerosis and hypercholesterolemia; and (e) glaucoma.
Patent NZ-527436-A (NZ)
Title: Dairy product and process for producing a milk protein concentrate high in whey protein and enhancing cheese yields
Inventor: CUKSEY SAMUEL DYLAN QUINN
IPC: A23C19/04
Filed: 2003-08-07
Abstract: A process for producing a protein composition is described. The process comprises: a) heating a dairy stream to a temperature in the range of 50oC to 95oC for a holding time of from 10 seconds to 30 minutes b) adjusting the pH of the stream to between 6.0 and about 8.0 c) adding a transglutaminase enzyme to the stream, maintaining the pH at between 6 and 8 and the temperature within the range 20oC to 65oC for a time sufficient to form a protein composition and then deactivating the transglutaminase enzyme d) cooling the stream where required, and e) adjusting the reaction conditions in the stream from step d) to cause coagulation of casein in the protein composition by either: i) adjusting the pH to less than 5.5 and adding an enzyme capable of converting kappa0casein or para-kappa casein into the stream to form a protein concentrate, or ii) adjusting the pH stream to about 4.5 to 48 to form a protein concentrate and f) recovering the protein concentrate formed. Also described is milk protein concentrate in which at least 50% of the whey protein in the dairy stream from which it was produced is bound to the casein from the dairy stream.
Patent NZ-528434-A (NZ)
Title: Improved aerator and mixer
Inventor: HENLEY BRUCE HYNDMAN
IPC: B01F23/00
Filed: 2003-09-24
Abstract: A device for use in aeration and mixing of wastewater is described. Aerator/mixer 2 is mounted on platform 3, supported above the waterline 5 by pontoons 4. Propeller 7 is below the liquid surface and coupled to motor 8 via coupling 9 and hollow drive shaft 10. A diffuser 11 is mounted on the drive shaft 10 behind the propeller. Air is passed from blower 14 through pipe 16 and inlet 15 into holes 14 in the drive shaft. The air then passes down the shaft into diffuser 11. The diffuser has multiple angled tapered holes in its wall, with the larger diameter of the holes being on the exterior surface in order to enhance the venturi effect and aid air flow to the diffuser. The design of diffuser 11 reduces the size of the bubbles introduced to the liquid in order to optimise aeration.
Patent NZ-529470-A (NZ)
Title: Apparatus and method for mixing and dispensing an additive-enhanced slurry
Inventor: WITTBOLD JAMES R
IPC: B28C5/38
Filed: 2002-07-03
Abstract: An apparatus and method for delivering an additive-enhanced slurry for use in making gypsum wallboard, and configured for connection to a centrifugal mixer with a tangential discharge outlet, includes a conduit having a main inlet in slurry receiving communication with the mixer outlet and extending to a discharge spout for discharging the slurry proximate a wallboard forming area. At least one volume restrictor is associated with the conduit for creating back pressure between the volume restrictor and the outlet for keeping the mixer full, and at least one pressure reducer associated with the discharge spout and configured for reducing the pressure of the slurry dispensed from the discharge spout. The apparatus is configured for maintaining a generally laminar flow from the mixer outlet to the discharge spout.
Patent NZ-531411-A (NZ)
Title: An attachment to a hydroponic conduit
Inventor: BOXSELL LYNETTE MAVIS
IPC: A01G31/02
Filed: 2002-07-25
Abstract: Hydroponic conduit (12) can be converted to drainage conduit by providing an attachment (10) on which a plant container can be supported. The attachment (10) comprises a circular plate (14) on which the plant containers sits, drainage means (ribs, grooves etc) and a central aperture (16) in the circular plate (14) to allow water to drain from the circular plate (14), and a short collar or spout on the bottom of the circular plate (14) which passes into an opening (13) in the hydroponic conduit (12) to allow water to drain into the conduit (12). A second support means (11) can be provided which is attached to the hydroponic conduit (12) and which provides additional support to the attachment (10).
Patent NZ-532009-A (NZ)
Title: Apparatus for shifting log sideways relative to grapple head assembly
Inventor: SHARP RODNEY WARWICK
IPC: B27B17/00
Filed: 2004-03-29
Abstract: In order to reposition a felled log for sawing with a grapple mounted saw, actuator 7 moves plate 15 with log gripper plates 14a, 14b so as to move the log along relative to the grapple head and jaws (not shown).
Patent NZ-534445-A (NZ)
Title: 1-apha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
Inventor: DELUCA HECTOR F
IPC: A61P25/28
Filed: 2002-12-10
Abstract: Disclosed herein is 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol of formula (I) and pharmaceutical uses thereof. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any calcemic activity and therefore may be used to treat immune disorders in humans as well as renal osteodystrophy.
Patent NZ-540157-A (NZ)
Title: LED display sign with angled transmission window
Inventor: MALEPA JEAN MARIE GILBERT
IPC: G09F9/302
Filed: 2005-05-20
Abstract: A message display sign includes a substantially planar transparent light transmission window 4 disposed adjacent the vertically arranged light-emitting pixel elements 2, 3 of the sign so that the angle a between the plane of the transmission window and the optical axis of the pixel elements is between 92O and 110O .
Patent NZ-541257-A (NZ)
Title: 14 kDa Moraxella Catarrhalis protein
Inventor: CRIPPS ALAN WILLIAM
Filed: 1999-05-11
Abstract: A protein derived from an antigen found on B. catarrhalis has a molecular weight of 14 kDa. The compositions of the protein are used for detecting or diagnosing B. catarrhalis and also used as a vaccine for the prophylaxis or treatment of respiratory infections.
Patent NZ-564801-A (NZ)
Title: Chelating agents for micronutrient fertilisers
Inventor: MCLAUGHLIN MIKE
IPC: C05D9/02
Filed: 2006-07-11
Abstract: Disclosed is a method of providing micronutrients to a plant, which includes applying to an area of the plant or soil/substrate surrounding the plant an effective amount of a plant fertiliser composition comprising a chelating polymer co-ordinately bonded to a micronutrient to form a chelate, the chelate transporting the micronutrient across a membrane of the plant and releasing the micronutrients within the plant for use by the plant, wherein the chelating polymer is a polythiol or polyamine, preferably having the structure of formula (I) wherein the variables are as defined in the specification.
Patent NZ-565534-A (NZ)
Title: SIMD lapped transform-based digital media encoding/decoding
Inventor: SRINIVASAN SRIDHAR
IPC: H04M11/04
Filed: 2006-08-03
Abstract: A digital media encoder or decoder comprises a data storage buffer for storing digital media data to be encoded and/or decoded and a processor programmed to order elements of blocks of digital media data to/from a set of vectors on which at least some operations of a lapped transform can be applied across the components of blocks on a single instruction, multiple data basis; apply the lapped transform to the blocks of the digital media data and encode/decode the digital media data to/from a compressed bitstream. The applying the lapped transform comprises performing the at least some operations on the single instruction, multiple data basis on the vectors for the block. Also disclosed is a method of encoding or decoding digital media data.
Patent NZ-569890-A (NZ)
Title: Milk tube including electrodes
Inventor: OBERMULLER HELMUT
IPC: H01B1/12
Filed: 2007-02-05
Abstract: A device including a milk-conveying tubular member (1) of an elastic material. The tubular member is positioned fluidically downstream from a teat-receiving part of a teatcup liner and is adapted to convey a flow of milk. The milk-conveying tubular member includes a wall having an outer surface (6a) and an inner surface (6b) facing an inner space (7) of the tubular member. A first electrode member (11) is provided in the wall and has a first contact surface (13) facing the inner space and provided to contact the milk flowing the tubular member. The first electrode member is formed by an electrically conducting polymer.
Patent NZ-573035-A (NZ)
Title: Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof
Inventor: KAKUDA SAHOE
IPC: A61K9/08
Filed: 2007-05-25
Abstract: Disclosed is an oral composition containing 3-{5-[4- (cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1, 2-benzisoxazol-6-yl)methoxy]phenyl}propionic acid or a salt thereof and polyvinylpyrrolidone.